• OPEN AN ACCOUNT
Indian Indices
Nifty
24,008.00 -265.80
(-1.10%)
Sensex
79,454.47 -880.34
( -1.10%)
Bank Nifty
53,595.25 -770.40
( -1.42%)
Nifty IT
35,880.10 -122.35
( -0.34%)
Global Indices
Nasdaq
41,380.81 245.84
(0.60%)
Dow Jones
5,684.33 32.05
(0.57%)
Hang Seng
37,492.25 563.62
(1.53%)
Nikkei 225
8,554.80 23.19
(0.27%)
Forex
USD-INR
84.70 0.29
(0.35%)
EUR-INR
96.08 0.41
(0.42%)
GBP-INR
112.96 0.38
(0.34%)
JPY-INR
0.59 0.00
(0.19%)

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
78788
INE0O5T01011
139.278683
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
REMUS
65.18
1095.29
EPS(TTM)
Face Value()
Div & Yield %
28.52
10
0
 

Polyplex Corporation Ltd - Board Meeting Outcome for Appointment Of Independent Director And Internal Auditors
Mar 27,2025
Board of Directors of Polyplex Corporation Limited (Company) at their meeting held on March 27 2025 have considered and approved: A. Appointment of Dr. Shalini Sarin (DIN: 06604529) as an Additional Non-Executive Independent Director of the Company with effect from March 30 2025 for a period of five consecutive years. She is not debarred from holding the office of a director pursuant to any order passed by the SEBI or any such authority. B. Appointment of Protiviti India Member Private Limited as Internal Auditors of the Company for a period of three years from April 1 2025 to March 31 2028